GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
GSK Dividend Announcement
• GSK announced a quarterly dividend of $0.39 per ordinary share which will be made payable on 2025-01-09. Ex dividend date: 2024-11-15
• GSK annual dividend for 2024 was $1.56
• GSK annual dividend for 2023 was $1.38
• GSK's trailing twelve-month (TTM) dividend yield is 4.42%
• GSK's payout ratio for the trailing twelve months (TTM) is 95.58%
• GSK's dividend growth over the last five years (2018-2023) was -4.37% year
• GSK's dividend growth over the last ten years (2013-2023) was -3.27% year
GSK Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-11-15 | $0.39 | quarterly | 2025-01-09 |
2024-08-16 | $0.39 | quarterly | 2024-10-10 |
2024-05-16 | $0.38 | quarterly | 2024-07-11 |
2024-02-22 | $0.41 | quarterly | 2024-04-11 |
2023-11-16 | $0.34 | quarterly | 2024-01-11 |
2023-08-17 | $0.36 | quarterly | 2023-10-12 |
2023-05-18 | $0.35 | quarterly | 2023-07-13 |
2023-02-23 | $0.33 | quarterly | 2023-04-13 |
2022-11-17 | $0.37 | quarterly | 2023-01-12 |
2022-08-18 | $0.38 | quarterly | 2022-10-06 |
2022-05-19 | $0.28 | quarterly | 2022-07-01 |
2022-02-24 | $0.50 | quarterly | 2022-04-07 |
2021-11-18 | $0.42 | quarterly | 2022-01-13 |
2021-08-19 | $0.42 | quarterly | 2021-10-07 |
2021-05-20 | $0.42 | quarterly | 2021-07-08 |
2021-02-18 | $0.50 | quarterly | 2021-04-08 |
2020-11-12 | $0.40 | quarterly | 2021-01-14 |
2020-08-13 | $0.39 | quarterly | 2020-10-08 |
2020-05-14 | $0.38 | quarterly | 2020-07-09 |
2020-02-20 | $0.48 | quarterly | 2020-04-09 |
2019-11-14 | $0.39 | quarterly | 2020-01-09 |
2019-08-08 | $0.37 | quarterly | 2019-10-10 |
2019-05-16 | $0.40 | quarterly | 2019-07-11 |
2019-02-21 | $0.48 | quarterly | 2019-04-11 |
2018-11-15 | $0.39 | quarterly | 2019-01-10 |
2018-08-09 | $0.40 | quarterly | 2018-10-11 |
2018-05-10 | $0.42 | quarterly | 2018-07-12 |
2018-02-22 | $0.51 | quarterly | 2018-04-12 |
2017-11-09 | $0.40 | quarterly | 2018-01-11 |
2017-08-09 | $0.40 | quarterly | 2017-10-12 |
2017-05-10 | $0.39 | quarterly | 2017-07-13 |
2017-02-22 | $0.46 | quarterly | 2017-04-13 |
2016-11-02 | $0.37 | quarterly | 2017-01-12 |
2016-08-10 | $0.40 | quarterly | 2016-10-13 |
2016-05-11 | $0.44 | quarterly | 2016-07-14 |
2016-02-17 | $1.00 | quarterly | 2016-04-14 |
2015-11-10 | $0.47 | quarterly | 2016-01-14 |
2015-08-12 | $0.47 | quarterly | 2015-10-01 |
2015-05-13 | $0.46 | quarterly | 2015-07-09 |
2015-02-18 | $0.56 | quarterly | 2015-04-09 |
2014-11-05 | $0.49 | quarterly | 2015-01-08 |
2014-08-06 | $0.52 | quarterly | 2014-10-02 |
2014-05-14 | $0.51 | quarterly | 2014-07-10 |
2014-02-19 | $0.60 | quarterly | 2014-04-10 |
2013-11-13 | $0.49 | quarterly | 2014-01-09 |
2013-08-07 | $0.44 | quarterly | 2013-10-03 |
2013-05-08 | $0.44 | quarterly | 2013-07-11 |
2013-02-20 | $0.55 | quarterly | 2013-04-11 |
GSK Dividend per year
GSK Dividend growth
GSK Dividend Yield
GSK current trailing twelve-month (TTM) dividend yield is 4.42%. Interested in purchasing GSK stock? Use our calculator to estimate your expected dividend yield:
GSK Financial Ratios
GSK Dividend FAQ
Other factors to consider when evaluating GSK as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy GSK stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: GSK's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, GSK publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, GSK distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from GSK are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: GSK sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, GSK distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: GSK declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of GSK's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review GSK's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.